GBI Research Market Research Reports

Title published price

Antibacterial Therapeutics - High levels of Pipeline Innovation Focused on the Increasing Unmet Need Associated with Antibiotic Resistance

By GBI Research

Summary Antibacterial resistance is currently believed to be responsible for over 700,000 deaths each year. As antibiotic resistance increases, due to the overuse and misuse of antibiotics, the number of avoidable deaths i ...

01-Feb-2018 $6995

Lower Female Reproductive System Cancers Drug Development Pipeline Review, 2017

By GBI Research

This report provides an overview of the Lower Female Reproductive System Cancers pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Cervic ...

26-Jan-2018 $3995

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

By GBI Research

This report provides an overview of the bladder and ureter pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for these two indications, and f ...

22-Jan-2018 $3995

Global Genetic Disorders Drugs Market to 2023 - A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease

By GBI Research

The genetic disorders therapy area consists of indications that arise because of an abnormality in a person’s DNA. This report focuses on the key therapy area indications of cystic fibrosis (CF), Duchenne muscular dystrophy (DMD), lysosomal ...

15-Dec-2017 $4995

COPD Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies

By GBI Research

Summary Chronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by obstruction of air flow that interferes with normal breathing. It occurs most often in older peo ...

01-Dec-2017 $4995

Global Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape

By GBI Research

Summary The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidem ...

01-Dec-2017 $4995

Frontier Pharma: Transplantation Therapeutics - A Highly Innovative Pipeline with a Range of Adaptive and Innate Immune-Targeting Programs Focusing on Graft-Versus-Host Disease and Kidney Transplantation

By GBI Research

Summary In 2015 a total of 127,000 transplantations were performed worldwide, an increase of 5.8% from 2014, with 33,000 of these occurring in the EU and 32,000 in the US. Approximately 60% of these were kidney transplants ...

01-Dec-2017 $6995

Swine and Avian Influenza Drug Development Pipeline Review, 2017

By GBI Research

H5N1 is a type of influenza virus that causes a highly infectious, severe respiratory disease in birds called avian influenza. This virus can spread to humans. There are a total of 63 products in development for this indication, by 47 companies an ...

20-Nov-2017 $3995

Sickle Cell Disease Drug Development Pipeline Review, 2017

By GBI Research

Sickle cell anemia is a genetic (inherited) blood disorder in which red blood cells, which carry oxygen around the body, develop abnormally. Signs and symptoms include anemia, delayed growth, vision problems, pain and frequent infections. There ar ...

17-Nov-2017 $3995

Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017

By GBI Research

Summary Gastric cancer, also called stomach cancer, is a malignant tumor arising from the lining of the stomach. Signs and symptoms of gastric cancer include fatigue, stomach pain, vomiting, weight loss that is unintention ...

16-Nov-2017 $3995

Cancer Supportive Care Drug Development Pipeline Review, 2017

By GBI Research

Summary Anorexia is defined as the loss of the desire to eat. Progressive wasting is common in many types of cancer and is one of the most important factors leading to early death in cancer patients. Advanced cancer underg ...

14-Nov-2017 $3995

Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy

By GBI Research

Summary Hemophilia is a rare disease affecting more than 400,000 people worldwide. Hemophilia A is four to six times as common as hemophilia B, and more than half of hemophilia A patients have a severe form of hemophilia. ...

01-Nov-2017 $4995

Frontier Pharma: Neurodegenerative Diseases - Protein Misfolding Targets and Neuromodulators Dominate the First-in-Class Pipeline and Lead the Way as Potential Disease-Modifying Therapies in AD and PD

By GBI Research

Summary Neurodegenerative diseases are becoming increasingly prevalent due to an aging population, but this diverse therapy area remains largely untreatable with current therapies. Neurodegenerative diseases are characteri ...

01-Nov-2017 $6995

Frontier Pharma: Renal Diseases - High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease

By GBI Research

Summary Kidneys are highly specialized organs that maintain a stable internal environment of the body - referred to as homeostasis - by selectively excreting, retaining and secreting various substances according to specifi ...

03-Oct-2017 $6995

Frontier Pharma: Ophthalmology Therapeutics - Gene Therapies and First-in-Class Targets Offer Novel Treatments for Substantial Unmet Needs in a Pipeline Dominated by Angiogenic and Immune Signaling Drugs

By GBI Research

Summary Ophthalmology is a therapy area that encompasses the diagnosis, treatment and prevention of diseases associated with the eyes and the visual system. The visual system, including the eye and its surrounding structur ...

01-Oct-2017 $6995

Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

By GBI Research

Diabetes mellitus refers to a group of metabolic diseases characterized by chronic hyperglycemia (high blood glucose levels) that results from defects in insulin secretion, insulin action, or both (ADA, 2014b). Insulin is a hormone that contribute ...

01-Oct-2017 $4995

Pneumonia Drug Development Pipeline Review, 2017

By GBI Research

Pneumonia Drug Development Pipeline Review, 2017 Summary Community acquired pneumonia refers to pneumonia contracted by a person who has had little contact with the healthcare system. There are a total of 20 products in deve ...

26-Sep-2017 $3995

Sleep Disorders Drug Development Pipeline Review, 2017

By GBI Research

Sleep Disorders Drug Development Pipeline Review, 2017 Summary Restless legs syndrome is characterized by a distressing, irresistible need or urge to move the legs. There are a total of eight products in development for this ...

26-Sep-2017 $3995

Male Health Drug Development Pipeline Review, 2017

By GBI Research

Male Health Drug Development Pipeline Review, 2017 Summary Male hypogonadism is characterized by androgen deficiency and infertility. Hypogonadism can be caused by disorders at the hypothalamic or pituitary level (hypogonado ...

25-Sep-2017 $3995

Colorectal Cancer Drug Development Pipeline Review, 2017

By GBI Research

Colorectal Cancer Drug Development Pipeline Review, 2017 Summary Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of fullness in the anal ...

22-Sep-2017 $3995